| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-05 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-05 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.16 | 1e-05 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.17 | 2e-05 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-05 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |